Dallas、TXにおける肥満症の臨床試験
Dallasとその周辺地域（約30マイル以内）の拠点で、肥満症に関する30件の研究が参加者を募集しています。研究を開いて、参加資格と連絡方法を確認してください。
公式研究テキスト（英語）
ここで研究参加者を募集していますか？ このページの上部に表示できます — 30日間 $99 →
Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities
被験者募集中第2相
- Velocity Clinical Research - Dallas /ID# 282734, Dallas
Spinal Cord Injury Model Systems (SCIMS) - Education Module
被験者募集中
- Baylor Scott & White Institute for Research, Dallas
AMAZE 2: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
被験者募集中第3相
- UT Southwestern Med Center, Dallas
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
被験者募集中第3相
- North Texas Endocrine Center, Dallas
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
被験者募集中第3相
- UT Southwestern Med Center, Dallas
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
被験者募集中第3相
- Velocity Clinical Res-Dallas, Dallas
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
被験者募集中第3相
- Velocity Clinical Research, Dallas, Dallas
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
被験者募集中第3相
- UT Southwestern Medical Center, Dallas
Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity
被験者募集中第3相
- Thyroid Endocrinology and Diabetes, Dallas
- Soltero Cardiovascular Research Center, Dallas
- Zenos Clinical Research, Dallas
- 他2件
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
被験者募集中第3相
- Velocity Clinical Research, Dallas, Dallas
- UT Southwestern Medical Center, Dallas
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
被験者募集中第2相
- FutureSearch Trials of Dallas, Dallas
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
被験者募集中第3相
- Cedar Health Research, LLC, Dallas
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
被験者募集中第3相
- Velocity Clinical Research, Dallas
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
被験者募集中第3相
- University of Texas Southwestern Medical Center - Children's Medical Center Dallas, Dallas
Research Study on How Well Oral Semaglutide Works for Weight Loss in Adults With Excess Body Weight
被験者募集中第3相
- Cedar Health Research, Dallas
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
被験者募集中第2相
- Velocity Clinical Research, Dallas, Dallas
- FutureSearch Trials of Dallas, Dallas
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
被験者募集中第2相
- Mercy Family Clinic, Dallas
- Velocity Clinical Research, Dallas, Dallas
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
被験者募集中第4相
- Modern Research Associates, PLLC, Dallas
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)
被験者募集中第3相
- Cedar Health Research, LLC, Dallas
Sympathetic Transduction in Obesity-associated Hypertension (OB-HTN)
被験者募集中早期第1相健康なボランティア歓迎
- University of Texas Southwestern Medical Center, Dallas
Effects of Obesity in the Aged
被験者募集中健康なボランティア歓迎
- Institute for Exercise and Environmental Medicine, UT Southwestern and Texas Health Resources, Dallas
Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
被験者募集中第2相
- University of Texas, Southwestern, Dallas
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
被験者募集中第3相
- Renal Disease Research Institute, Dallas
- Texas Health Heart and Vascular Specialists, Dallas
- Southwest Family Medicine_Dallas, Dallas
- 他1件
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
被験者募集中第3相
- Mercy Family Clinic, Dallas
A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
被験者募集中第2相
- Velocity Clinical Research Dallas, Dallas
UTSW NORC Pilot Spinal Cord Injury Dietary Program
被験者募集中
- University of Texas Southwestern Medical Center, Dallas
Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF
被験者募集中健康なボランティア歓迎
- UT Southwestern Medical Center, Dallas
Leg Heating in Pregnant Women With Obesity
被験者募集中健康なボランティア歓迎
- UT Southwestern Medical Center; Institute for Exercise and Environmental Medicine, Dallas
Comparing Outcomes Among Children With Obesity in a Community Healthy Lifestyle Program
被験者募集中
- University of Texas Southwestern, Children's Health, Dallas
Healthy Living BEYOND Weight Study
被験者募集中観察研究
- American Heart Association, Dallas
他の都市における肥満症の試験
- Houston, TX43件の研究
- Chicago, IL41件の研究
- New York City, NY40件の研究
- San Antonio, TX40件の研究
- Washington, DC33件の研究
- Orlando, FL31件の研究
- Boston, MA28件の研究
- Las Vegas, NV27件の研究
- Miami, FL27件の研究
- Baltimore, MD25件の研究
- Jacksonville, FL25件の研究
- St. Louis, MO25件の研究
Dallasにおける他の研究
- 乳がん55件の研究
- 非小細胞肺癌52件の研究
- 転移性癌42件の研究
- 心不全42件の研究
- がん（全種類）37件の研究
- 前立腺がん36件の研究
- 大腸癌33件の研究
- 卵巣がん28件の研究
- 膀胱癌27件の研究
- 肺がん27件の研究
- 子宮内膜がん24件の研究
- 心血管疾患23件の研究
ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。